Loading stock data…
electroCore, Inc. (ECOR)
$8.12+0.28 (+3.57%)
After Hours$7.31-0.81 (-9.93%)· Last close Jun 29
electroCore, Inc., a bioelectronic technology medicine and general wellness company, provides non-invasive vagus nerve stimulation (nVNS) technology platform in the United States, the United Kingdom, and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
electroCore, Inc. in the Healthcare sector is trading at $8.12 with a market capitalization of $82M. Wall Street consensus targets $19.17 (5 analysts), implying a +136.1% move over the next 12 months. The stock is currently 23% below its 52-week high of $10.49, remaining 31.4% above its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals, Altman Z in the distress zone. The Whystock Score of 80/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +136.1% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $9.58M↑ | $9.24M↑ | $8.69M↑ | $7.38M↑ | $6.72M |
| Gross Profit | $8.36M↑ | $8.17M↑ | $7.47M↑ | $6.44M↑ | $5.71M |
| Operating Income | -$5.32M↓ | -$2.94M↓ | -$2.88M↑ | -$3.51M↑ | -$3.82M |
| Net Income | -$5.27M↓ | -$3.04M↑ | -$3.40M↑ | -$3.67M↑ | -$3.85M |
Peer Comparison
JNJUNHPFE
Fundamentals
electroCore, Inc., a bioelectronic technology medicine and general wellness company, provides non-invasive vagus nerve stimulation (nVNS) technology platform in the United States, the United Kingdom, and internationally. The company develops gammaCor...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$81.80M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
0.68
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
270.43%
Volume
Today's trading volume
128,320
Recent News
electroCore Touts 30% Growth Outlook, VA Opportunity at LD Micro Conference
electroCore (NASDAQ:ECOR) Interim President and CFO Joshua Lev said the bioelectronic technology company is focused on expanding its non-invasive vagus nerve stimulation platform across federal health care, commercial insurance channels and consumer wellness markets. Speaking at the LD Micro event,
electroCore (ECOR) Q1 2026 Earnings Transcript
Thomas Errico: Good afternoon, everyone, and thank you for joining electroCore, Inc.'s first quarter 2026 earnings call. This is the first earnings call since we announced our leadership transition, and I want to take a moment to share how encouraged I am by the progress we have made executing that transition and by the momentum we continue to see across the organization. At the same time, Michael Fox joined us as chief operating officer on April 13, bringing more than 35 years of commercial leadership experience across complex healthcare markets, including extensive work within the federal systems and the U.S. Department of Veteran Affairs.
electroCore, Inc. Q1 2026 Earnings Call Summary
Moby summary of electroCore, Inc.'s Q1 2026 earnings call
electroCore Q1 Earnings Call Highlights
electroCore (NASDAQ:ECOR) executives highlighted record quarterly revenue, expanding margins, and continued progress toward profitability during the company’s first-quarter 2026 earnings call, while also discussing a leadership transition and commercial priorities across federal and consumer channel
electroCore, Inc. (ECOR) Reports Q1 Loss, Beats Revenue Estimates
electroCore (ECOR) delivered earnings and revenue surprises of -0.86% and +7.14%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?